The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
The success and failure of BCG — implications for a novel tuberculosis vaccine
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature
Colditz, G. A. (1994) · JAMA · doi:10.1001/jama.1994.03510330076038 · Cited by 1,918
Variation in protection by BCG: implications of and for heterologous immunity
Fine, P. E. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92348-9 · Cited by 1,380
Epidemiology of infection by nontuberculous mycobacteria
Falkinham, J. O. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.2.177 · Cited by 1,113
Global Tuberculosis Control 2011, WHO Report 2011
Behera, D. (2012) · The Indian Journal of Medical Research · Cited by 1,022
Colditz, G. A., Berkey, C. S., Mosteller, F., Brewer, T. F., Wilson, M. E., Burdick, E., & Fineberg, H. V. (1995) · Pediatrics · doi:10.1542/peds.96.1.29 · Cited by 763
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis
Pym, A. S., Brodin, P., Majlessi, L., Brosch, R., Demangel, C., Williams, A., Griffiths, K. E., Marchal, G., Leclerc, C., & Cole, S. T. (2003) · Nature Medicine · doi:10.1038/nm859 · Cited by 644
Exogenous Reinfection as a Cause of Recurrent Tuberculosis after Curative Treatment
van Rie, A., Warren, R., Richardson, M., Victor, T. C., Gie, R. P., Enarson, D. A., Beyers, N., & van Helden, P. D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411602 · Cited by 610
McShane, H., Pathan, A. A., Sander, C. R., Keating, S. M., Gilbert, S. C., Huygen, K., Fletcher, H. A., & Hill, A. V. S. (2004) · Nature Medicine · doi:10.1038/nm1128 · Cited by 570
Hart, P. D., & Sutherland, I. (1977) · BMJ · doi:10.1136/bmj.2.6082.293 · Cited by 519
Brandt, L., Feino Cunha, J., Weinreich Olsen, A., Chilima, B., Hirsch, P., Appelberg, R., & Andersen, P. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.672-678.2002 · Cited by 453
Self-citationHorwitz, M. A., Harth, G., Dillon, B. J., & Masleša-Galić, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250480397 · Cited by 436
Goonetilleke, N. P., McShane, H., Hannan, C. M., Anderson, R. J., Brookes, R. H., & Hill, A. V. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1602 · Cited by 360
Wang, J., Thorson, L., Stokes, R. W., Santosuosso, M., Huygen, K., Zganiacz, A., Hitt, M., & Xing, Z. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6357 · Cited by 359
Olsen, A. W., van Pinxteren, L. A. H., Okkels, L. M., Rasmussen, P. B., & Andersen, P. (2001) · Infection and Immunity · doi:10.1128/iai.69.5.2773-2778.2001 · Cited by 344
Self-citationLong-term Efficacy of BCG Vaccine in American Indians and Alaska Natives: A 60-Year Follow-up Study
Aronson, N. E., Santosham, M., Comstock, G. W., Howard, R. S., Moulton, L. H., Rhoades, E. R., & Harrison, L. H. (2004) · JAMA · doi:10.1001/jama.291.17.2086 · Cited by 338
Skeiky, Y. A. W., Alderson, M. R., Ovendale, P. J., Guderian, J. A., Brandt, L., Dillon, D. C., Campos-Neto, A., Lobet, Y., Dalemans, W., Orme, I. M., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7618 · Cited by 313
Does the efficacy of BCG decline with time since vaccination?
Sterne, J. A. C., Rodrigues, L. C., & Guedes, I. N. (1998) · PubMed · Cited by 310
Black, G. F., Weir, R. E., Floyd, S., Bliss, L., Warndorff, D. K., Crampin, A. C., Ngwira, B., Sichali, L., Nazareth, B., Blackwell, J. M., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08353-8 · Cited by 306
Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis.
Palmer, C., & Long, M. W. (1966) · PubMed · doi:10.1164/arrd.1966.94.4.553 · Cited by 292
Preventing Tuberculosis with Bacillus Calmette-Guérin Vaccine: A Meta-Analysis of the Literature
Brewer, T. F. (2000) · Clinical Infectious Diseases · doi:10.1086/314072 · Cited by 283
Langermans, J. A. M., Doherty, T. M., Vervenne, R. A. W., Laan, T. V. D., Lyashchenko, K., Greenwald, R., Agger, E. M., Aagaard, C., Weiler, H., Soolingen, D. V., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.11.051 · Cited by 247
Self-citationLillebaek, T., Dirksen, A., Baess, I., Strunge, B., Thomsen, V. Ø., & Andersen, Å. B. (2002) · The Journal of Infectious Diseases · doi:10.1086/338342 · Cited by 234
McShane, H., Brookes, R., Gilbert, S. C., & Hill, A. V. S. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.681-686.2001 · Cited by 231
Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi
Ponnighaus, J. M., Msosa, E., Gruer, P. J. K., Liomba, N. G., Fine, P. E. M., Sterne, J. A. C., Wilson, R. J., Bliss, L., Jenkins, P. A., & Lucas, S. B. (1992) · The Lancet · doi:10.1016/0140-6736(92)90794-4 · Cited by 208
Horwitz, M. A., & Harth, G. (2003) · Infection and Immunity · doi:10.1128/iai.71.4.1672-1679.2003 · Cited by 201
Oettinger, T., Jørgensen, M., Ladefoged, A., Hasløv, K., & Andersen, P. (1999) · Tubercle and Lung Disease · doi:10.1054/tuld.1999.0206 · Cited by 190
Self-citationDelayed-type hypersensitivity, mycobacterial vaccines and protective immunity
Fine, P. E. M., Sterne, J. A. C., Pönnighaus, J. M., & Rees, R. J. W. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90748-x · Cited by 182
Brandt, L., Skeiky, Y. A. W., Alderson, M. R., Lobet, Y., Dalemans, W., Turner, O. C., Basaraba, R. J., Izzo, A. A., Lasco, T. M., Chapman, P. L., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6622-6632.2004 · Cited by 174
Holten-Andersen, L., Doherty, T. M., Korsholm, K. S., & Andersen, P. (2004) · Infection and Immunity · doi:10.1128/iai.72.3.1608-1617.2004 · Cited by 172
Self-citationWilliams, A., Hatch, G. J., Clark, S. O., Gooch, K. E., Hatch, K. A., Hall, G. A., Huygen, K., Ottenhoff, T. H. M., Franken, K. L. M. C., Andersen, P., et al. (2005) · Tuberculosis · doi:10.1016/j.tube.2004.09.009 · Cited by 168
Self-citationBuddle, B. M., Wards, B. J., Aldwell, F. E., et al. (2002) · Vaccine · doi:10.1016/s0264-410x(01)00436-4 · Cited by 154
Epidemiology of Infection by Nontuberculous Mycobacteria
Martin, E. C., Parker, B. C., & Falkinham, J. O. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.2.344 · Cited by 136
Tuberculosis prevention Trial, Madras.
Baily, G. V. J. (1980) · PubMed · Cited by 131
Has BCG attenuated to impotence?
Behr, M. A., & Small, P. M. (1997) · Nature · doi:10.1038/38151 · Cited by 127
Black, G. F., Dockrell, H. M., Crampin, A. C., Floyd, S., Weir, R. E., Bliss, L., Sichali, L., Mwaungulu, L., Kanyongoloka, H., Ngwira, B. M., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/322042 · Cited by 126
Comparative genomics of the mycobacteria
Brosch, R., Gordon, S. V., Pym, A. S., Eiglmeier, K., Garnier, T., & Cole, S. T. (2000) · International Journal of Medical Microbiology · doi:10.1016/s1438-4221(00)80083-1 · Cited by 125
Geographic Latitude and the Efficacy of Bacillus Calmette-Guerin Vaccine
Wilson, M. E., Hv, F., & Colditz, G. A. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.4.982 · Cited by 113
Analysis of the Genome of Mycobacterium tuberculosis H37Rv
Cole, S. T., & Barrell, B. G. (1998) · Novartis Foundation symposium · doi:10.1002/0470846526.ch12 · Cited by 107
Demangel, C., Garnier, T., Rosenkrands, I., & Cole, S. T. (2005) · Infection and Immunity · doi:10.1128/iai.73.4.2190-2196.2005 · Cited by 99
von Reyn, C. F., Horsburgh, C. R., Olivier, K. N., Barnes, P. F., Waddell, R. D., Warren, C., Tvaroha, S., Jaeger, A. S., Lein, A. D., Alexander, L. N., et al. (2001) · PubMed · Cited by 93
Harboe, M., Mshana, R. N., CLOSS, O., Kronvall, G., & AXELSEN, N. H. (1979) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1979.tb02713.x · Cited by 89
CLOSS, O., Harboe, M., & WASSUM, A. M. (1975) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1975.tb03824.x · Cited by 80
Black, G. F., Fine, P., Warndorff, D. K., et al. (2001) · PubMed · Cited by 78
Tuberculosis vaccine development
Doherty, T. M., & Andersen, P. L. (2002) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200205000-00006 · Cited by 69
Self-citationvon Reyn, C. F., Williams, D. E., Horsburgh, Jr., Jaeger, A. S., Marsh, B. J., Haslov, K., & Magnusson, M. (1998) · The Journal of Infectious Diseases · doi:10.1086/514225 · Cited by 62
Does the Protective Effect of Neonatal BCG Correlate With Vaccine-Induced Tuberculin Reaction?
Al‐Kassimi, F. A., Al‐Hajjaj, M. S., Al-Orainey, I. O. M., & Bamgboye, E. A. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.5.7582297 · Cited by 59
Correlation between BCG Genomics and Protective Efficacy
Behr, M. A. (2001) · Scandinavian Journal of Infectious Diseases · doi:10.1080/003655401300077180 · Cited by 59
Comparative genomics of the leprosy and tubercle bacilli
Brosch, R., Gordon, S. V., Eiglmeier, K., Garnier, T., & Cole, S. T. (2000) · Research in Microbiology · doi:10.1016/s0923-2508(00)00117-0 · Cited by 55
Miceli, I. N. P., Kantor, I. N., COLAIÁCOVO, D., et al. (1988) · International Journal of Epidemiology · doi:10.1093/ije/17.3.629 · Cited by 54
Tuberculosis: Distribution, Risk Factors, Mortality
Kochi, A. (1994) · Immunobiology · doi:10.1016/s0171-2985(11)80437-7 · Cited by 51
The Koch Phenomenon and the Immunopathology of Tuberculosis
Rook, G. A. W., & Stanford, J. L. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-80166-2_11 · Cited by 42
Specificity of tuberculins and antigens from various species of mycobacteria.
Chaparas, S. D., Maloney, C. J., & Hedrick, S. R. (1970) · PubMed · doi:10.1164/arrd.1970.101.1.74 · Cited by 41
Weir, R. E., Fine, P., Nazareth, B., et al. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02272 · Cited by 41
Does B.C.G. vaccination prevent or postpone the occurrence of tuberculous meningitis?
Mittal, S. K., Aggarwal, V., Rastogi, A., et al. (1996) · The Indian Journal of Pediatrics · doi:10.1007/bf02730815 · Cited by 36
Evaluation of adjuvants for protein vaccines against tuberculosis in guinea pigs
Hogarth, P. J., Jahans, K., Hecker, R., Hewinson, R. G., & Chambers, M. A. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00548-0 · Cited by 31
Conradt, P., Hess, J., & Kaufmann, S. H. E. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)80077-x · Cited by 31
Davies, P. D. O. (1993) · Respiratory Medicine · doi:10.1016/0954-6111(93)90104-8 · Cited by 22
Tsuchihashi (2000) · doi:10.1002/1521-4141(200006)30:6
Cited by
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Darrah, P. A., Patel, D. T., De Luca, P. M., Lindsay, R. W. B., Davey, D. F., Flynn, B. J., Hoff, S. T., Andersen, P., Reed, S. G., Morris, S. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1592 · Cited by 1,378
Self-citationThe Immune Response in Tuberculosis
O'Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,342
Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials
Mangtani, P., Abubakar, I., Ariti, C., Beynon, R., Pimpin, L., Fine, P. E. M., Rodrigues, L. C., Smith, P. G., Lipman, M., Whiting, P. F., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit790 · Cited by 995
Variable host–pathogen compatibility in Mycobacterium tuberculosis
Gagneux, S., DeRiemer, K., Van, T., Kato-Maeda, M., de Jong, B. C., Narayanan, S., Nicol, M., Niemann, S., Kremer, K., Gutierrez, M. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511240103 · Cited by 971
Designing of interferon-gamma inducing MHC class-II binders
Dhanda, S. K., Vir, P., & Raghava, G. P. (2013) · Biology Direct · doi:10.1186/1745-6150-8-30 · Cited by 837
Metadata
- Authors
- Andersen, P., & Doherty, T. M.
- Venue
- Nature Reviews Microbiology
- Published
- 2005-07-11
- Volume
- 3
- Issue
- 8
- Pages
- 656-662
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W1546213590
- Cited by
- 788
- References
- 59
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.